Active Monitoring May Be a Safe Treatment Option for Many Women with DCIS Breast Cancer, New Study Suggests

• December 14, 2024
• HealthDayTV HealthDay Reporter

In a new study, women with low-risk DCIS breast cancer who underwent active monitoring had similar recurrence rates as women who underwent surgery to remove their cancer.

Health News is provided as a service to Pharmcare Pharmacy site users by HealthDay. Pharmcare Pharmacy nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.

Copyright © 2025 HealthDay All Rights Reserved.

Tags